IP Library Granted Patent US 11,672,696
Granted Patent B2
US 11,672,696 · App. 16/832,102 · Granted Jun 13, 2023

Therapeutic agent delivery device with convergent lumen

Inventors: Joseph H. Contiliano (Stewartsville, NJ); Thomas E. Meyer (Philadelphia, PA); Daniel J. Abbott (Maple Valley, WA); Michael F. Keane (Downingtown, PA); Allen C. Ho (Lower Gwynedd, PA); Mark C. Tsai (Chalfont, PA); Isaac J. Khan (Bridgewater, NJ)
Assignee: Gyroscope Therapeutics Limited
A61F9/0008A61F9/0017A61M25/065A61M25/0662A61F9/0026A61M2025/0681
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,672,696
App. No.
16/832,102
Granted
Jun 13, 2023
Kind
B2
Abstract

An apparatus has a first fluid conduit, a second fluid conduit, a connector member, an first tubular member, a second tubular member, and an inner cannula. The connector member has first and second passageways in which the first and second fluid conduits are positioned, respectively. A portion of the second tubular member is positioned within the lumen of the first tubular member. A proximal portion of the inner cannula is fixedly secured within the lumen of the first tubular member. The inner cannula lumen is in fluid communication with the first and second fluid conduits via the lumen of the first tubular member and the lumen of the second tubular member. The inner cannula may be inserted into the subretinal space of a human eye to deliver a leading bleb of fluid and then deliver a therapeutic agent, without having to withdraw the inner cannula from the subretinal space between the acts of delivering the leading bleb delivering the therapeutic agent.

Claims (42)

1. A method comprising:

(a) inserting an instrument through an anterior region of a patient's eye, the instrument including a first cannula and a second cannula slidably disposed in the first cannula, the act of inserting the instrument through the anterior region of the patient's eye comprising inserting the first cannula through the anterior region of the patient's eye;

(b) traversing a vitreous region of the patient's eye with the instrument;

(c) positioning a distal portion of the instrument at a posterior region of the patient's eye, adjacent to a retina of the patient's eye, the act of positioning the distal portion of the instrument at the posterior region of the patient's eye comprising advancing a distal portion of the second cannula to the Posterior region of the patient's eye;

(d) advancing a fluid delivery element of the instrument through the retina; and

(e) delivering a fluid to the posterior region of the patient's eye via the advanced fluid delivery element.

2. The method of claim 1 , the second cannula defining the fluid delivery element, the act of advancing the fluid delivery element of the instrument through the retina comprising advancing the distal portion of the second cannula through the retina.

3. The method of claim 1 , the second cannula being formed of a polymeric material.

4. The method of claim 1 , the second cannula having a blunt distal tip.

5. The method of claim 1 , the distal portion of the second cannula being positioned proximally relative to a distal end of the first cannula during the act of inserting the instrument through the anterior region of the patient's eye.

6. The method of claim 1 , further comprising arresting advancement of the fluid delivery element after a distal end of the fluid delivery element reaches a subretinal space in the patient's eye, the subretinal space being located between the retina and a choroid layer in the patient's eye, the act of arresting advancement of the fluid delivery element being performed after completing the act of advancing the fluid delivery element of the instrument through the retina and before performing the act of delivering the fluid to the posterior region of the patient's eye via the advanced fluid delivery element.

7. The method of claim 1 , the act of delivering the fluid to the posterior region of the patient's eye comprising delivering the fluid between two layers of the patient's eye.

8. The method of claim 7 , the two layers comprising the retina and a choroid layer, such that the fluid is delivered to a subretinal space.

9. The method of claim 1 , the act of delivering the fluid to the posterior region of the patient's eye comprising:

(i) delivering a first kind of fluid to the posterior region of the patient's eye, and

(ii) delivering a second kind of fluid to the posterior region of the patient's eye.

10. The method of claim 9 , the first kind of fluid comprising a leading bleb fluid, the second kind of fluid comprising a therapeutic agent.

11. The method of claim 9 , the instrument remaining inserted through the anterior region of the patient's eye during the acts of delivering the first kind of fluid and delivering the second kind of fluid, such that the instrument is not removed from the anterior region of the patient's eye between the act of delivering the first kind of fluid and the act of delivering the second kind of fluid.

12. The method of claim 1 , the act of delivering the fluid to the posterior region of the patient's eye comprising:

(i) delivering a first volume of fluid at a first location in the posterior region of the patient's eye, and

(ii) delivering a second volume of fluid at a second location in the posterior region of the patient's eye.

13. The method of claim 12 , the first volume of fluid comprising a leading bleb fluid, the second volume of fluid comprising a therapeutic agent.

14. The method of claim 12 , the instrument remaining inserted through the anterior region of the patient's eye during the acts of delivering the first volume of fluid and delivering the second volume of fluid, such that the instrument is not removed from the anterior region of the patient's eye between the act of delivering the first volume of fluid and the act of delivering the second volume of fluid.

15. The method of claim 1 , further comprising aspirating at least some of the delivered fluid from the posterior region of the patient's eye.

16. The method of claim 1 , further comprising performing a retinopexy on the retina, at a point where the fluid delivery element advanced through the retina, after completing the act of delivering the fluid to the posterior region of the patient's eye.

17. The method of claim 1 , the act of positioning the distal portion of the instrument at the posterior region of the patient's eye further comprising advancing a distal portion of the first cannula to the posterior region of the patient's eye, adjacent to the retina.

18. The method of claim 1 , further comprising advancing the fluid delivery element of the instrument along a space between the retina and a choroid layer of the patient's eye after advancing the fluid delivery element through the retina.

19. A method comprising:

(a) inserting an instrument through an anterior region of a patient's eye;

(b) traversing a vitreous region of the patient's eye with the instrument;

(c) positioning a distal portion of the instrument at a posterior region of the patient's eye, adjacent to a retina of the patient's eye;

(d) advancing a fluid delivery element of the instrument through the retina;

(e) delivering a leading bleb fluid to the posterior region of the patient's eye via the advanced fluid delivery element;

(f) advancing the fluid delivery element along a space between the retina and a choroid layer of the patient's eye after delivering the leading bleb fluid; and

(g) delivering a therapeutic agent to the posterior region of the patient's eye via the advanced fluid delivery element after delivering the leading bleb fluid and after advancing the fluid delivery element between the retina and the choroid layer.

20. A method comprising:

(a) inserting a first cannula of an instrument through an anterior region of a patient's eye;

(b) traversing a vitreous region of the patient's eye with the first cannula of the instrument;

(c) positioning a distal portion of the first cannula of the instrument at a posterior region of the patient's eye, adjacent to a retina of the patient's eye;

(d) advancing a second cannula defining a fluid delivery element of the instrument through the retina;

(e) arresting advancement of the second cannula defining the fluid delivery element when a distal end of the fluid delivery element reaches a subretinal space between the retina and a choroid layer of the patient's eye; and

(f) delivering a therapeutic agent to the subretinal space via the advanced fluid delivery element.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2024
From: GYROSCOPE THERAPEUTICS LIMITED
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 069091/0527 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2024
From: F. HOFFMANN-LA ROCHE AG
To: GENENTECH, INC.
Reel/Frame 069097/0746 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNOR SHOULD READ "ORBIT BIOMEDICAL LIMITED" PREVIOUSLY RECORDED ON REEL 053762 FRAME 0437. ASSIGNOR(S) HEREBY CONFIRMS THE THE ORIGINAL READ "ORBIT BIOMEDICAL LIMTED". Recorded Sep 23, 2020
From: ORBIT BIOMEDICAL LIMITED
To: GYROSCOPE THERAPEUTICS LIMITED
Reel/Frame 053856/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2020
From: ORBIT BIOMEDICAL LIMTED
To: GYROSCOPE THERAPEUTICS LIMITED
Reel/Frame 053762/0437 →
Continuity (4)
Continuation 15924395 · Mar 19, 2018
Continuation 14726786 · Jun 1, 2015
Provisional Application 62008745 · Jun 6, 2014
Related Publication 20200222232A1 · Jul 16, 2020